» Articles » PMID: 15522867

Stimulus-specific Induction of a Novel Nuclear Factor-kappaB Regulator, IkappaB-zeta, Via Toll/Interleukin-1 Receptor is Mediated by MRNA Stabilization

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2004 Nov 4
PMID 15522867
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

We have recently identified an inducible nuclear factor-kappaB (NF-kappaB) regulator, IkappaB-zeta, which is induced by microbial ligands for Toll-like receptors such as lipopolysaccharide and the proinflammatory cytokine interleukin (IL)-1beta but not by tumor necrosis factor (TNF)-alpha. In the present study, we examined mechanisms for stimulus-specific induction of IkappaB-zeta. The analysis of the IkappaB-zeta promoter revealed an essential role for an NF-kappaB binding sequence in transcriptional activation. The activation, however, did not account for the Toll-like receptor/IL-1 receptor-specific induction of IkappaB-zeta, because the promoter analysis and nuclear run-on analysis indicated that its transcription was similarly induced by TNF-alpha. To examine post-transcriptional regulation, we analyzed the decay of IkappaB-zeta mRNA, and we found that it was specifically stabilized by lipopolysaccharide or IL-1beta but not by TNF-alpha. Furthermore, we found that costimulation with TNF-alpha and another proinflammatory cytokine, IL-17, elicited the IkappaB-zeta induction. Stimulation with IL-17 alone did not induce IkappaB-zeta but stabilized its mRNA. Therefore, IkappaB-zeta induction requires both NF-kappaB activation and stimulus-specific stabilization of its mRNA. Because IkappaB-zeta is essential for expression of a subset of NF-kappaB target genes, the stimulus-specific induction of IkappaB-zeta may be of great significance in regulation of inflammatory reactions.

Citing Articles

The Nuclear NF-κB Regulator IκBζ: Updates on Its Molecular Functions and Pathophysiological Roles.

Yamazaki S Cells. 2024; 13(17.

PMID: 39273036 PMC: 11393961. DOI: 10.3390/cells13171467.


Selective regulation of a defined subset of inflammatory and immunoregulatory genes by an NF-κB p50-IκBζ pathway.

Daly A, Yeh G, Soltero S, Smale S Genes Dev. 2024; 38(11-12):536-553.

PMID: 38918046 PMC: 11293394. DOI: 10.1101/gad.351630.124.


LINC01686 affects LPS-induced cytokine expression via the miR-18a-5p/A20/STAT1 axis in THP-1 cells.

Baek J, Shin H, Suk K, Lee W Immun Inflamm Dis. 2024; 12(4):e1234.

PMID: 38578001 PMC: 10996380. DOI: 10.1002/iid3.1234.


IκBζ is a dual-use coactivator of NF-κB and POU transcription factors.

Alpsoy A, Wu X, Pal S, Klingbeil O, Kumar P, El Demerdash O Mol Cell. 2024; 84(6):1149-1157.e7.

PMID: 38309274 PMC: 10960667. DOI: 10.1016/j.molcel.2024.01.007.


The IL-17 family in diseases: from bench to bedside.

Huangfu L, Li R, Huang Y, Wang S Signal Transduct Target Ther. 2023; 8(1):402.

PMID: 37816755 PMC: 10564932. DOI: 10.1038/s41392-023-01620-3.